H. M. de Wit

Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT)

H. M. de Wit, Gerald Vervoort, Henry Jansen et al. · Diabetologia · 2014 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Insulin administered by needle‐free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes

H. M. de Wit, Elsemiek E.C. Engwerda, Cees J. Tack et al. · Diabetes Obesity and Metabolism · 2015 · 26 citations

Medicine, Pharmacokinetics, Pharmacology +17

MIDD or MELAS : that's not the question MIDD evolving into MELAS : a severe phenotype of the m.3243A>G mutation due to paternal co-inheritance of type 2 diabetes and a high heteroplasmy level.

H. M. de Wit, Henk‐Jan Westeneng, Baziel G.M. van Engelen et al. · PubMed · 2012 · 21 citations

Life Sciences, Genetics, Molecular Genetics +8

Durable efficacy of liraglutide in patients with type 2 diabetes and pronounced insulin‐associated weight gain: 52‐week results from the Effect of Liraglutide on insulin‐associated <scp>wE</scp>ight <scp>GA</scp>iN in patients with Type 2 diabetes' (<scp>ELEGANT</scp>) randomized controlled trial

H. M. de Wit, Griet Vervoort, Henry Jansen et al. · Journal of Internal Medicine · 2015 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Incorrect Performance of the Breath Hold Method in the Old Underestimates Cerebrovascular Reactivity and Goes Unnoticed Without Concomitant Blood Pressure and End-Tidal CO2 Registration

Arenda HEA van Beek, H. M. de Wit, Marcel G. M. Olde Rikkert et al. · Journal of Neuroimaging · 2011 · 14 citations

Life Sciences, Physiology, Exercise Physiology +12